Jerry Fischer, MD, PHD

NPI: 1376654780
Total Payments
$3,680
2024 Payments
$28.90
Companies
3
Transactions
8

Payment Breakdown by Category

Other$3,150 (85.6%)
Travel$340.34 (9.2%)
Food & Beverage$189.58 (5.2%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3,150 2 85.6%
Travel and Lodging $340.34 2 9.2%
Food and Beverage $189.58 4 5.2%

Top Paying Companies

Company Total Records Latest Year
Takeda Pharmaceuticals America, Inc. $3,533 6 $0 (2017)
Novartis Pharmaceuticals Corporation $118.00 1 $0 (2017)
Gilead Sciences, Inc. $28.90 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $28.90 1 Gilead Sciences, Inc. ($28.90)
2017 $3,651 7 Takeda Pharmaceuticals America, Inc. ($3,533)

All Payment Transactions

8 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
04/24/2024 Gilead Sciences, Inc. Epclusa (Drug) Food and Beverage In-kind items and services $28.90 General
Category: HCV
02/22/2017 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $118.00 General
Category: CARDIOVASCULAR
02/08/2017 Takeda Pharmaceuticals America, Inc. Uloric (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $2,150.00 General
Category: Gout/Rheumatology
02/08/2017 Takeda Pharmaceuticals America, Inc. Uloric (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,000.00 General
Category: Gout/Rheumatology
02/08/2017 Takeda Pharmaceuticals America, Inc. Uloric (Drug) Travel and Lodging Cash or cash equivalent $203.30 General
Category: Gout/Rheumatology
02/08/2017 Takeda Pharmaceuticals America, Inc. Uloric (Drug) Travel and Lodging Cash or cash equivalent $137.04 General
Category: Gout/Rheumatology
01/31/2017 Takeda Pharmaceuticals America, Inc. Food and Beverage In-kind items and services $3.15 General
01/24/2017 Takeda Pharmaceuticals America, Inc. Uloric (Drug) Food and Beverage Cash or cash equivalent $39.53 General
Category: Gout/Rheumatology

About Jerry Fischer, MD, PHD

Jerry Fischer, MD, PHD is a Nephrology healthcare provider based in Omaha, Nebraska. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1376654780.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jerry Fischer, MD, PHD has received a total of $3,680 in payments from pharmaceutical and medical device companies, with $28.90 received in 2024. These payments were reported across 8 transactions from 3 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($3,150).

Practice Information

  • Specialty Nephrology
  • Location Omaha, NE
  • Active Since 08/31/2006
  • Last Updated 04/10/2019
  • Taxonomy Code 207RN0300X
  • Entity Type Individual
  • NPI Number 1376654780

Products in Payments

  • Uloric (Drug) $3,530
  • ENTRESTO (Drug) $118.00
  • Epclusa (Drug) $28.90

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nephrology Doctors in Omaha